Pain Management Drugs Market Growth & Key Business Strategies by Leading Industry Players "Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., & Many Others"

The Global Pain Management Drugs Market is estimated to reach from $58,577 million in 2016, $77,131 million by 2023. It is anticipated to register a CAGR of 4% during the forecast period, 2017-2023.

"Increase in prevalence of cancer and rise in number of surgeries conducted per year have fueled the demand for nonsteroidal anti-inflammatory drugs, and opioids in the market, thereby driving the market growth. As per the statistics provided by the World Bank, almost 4,511.1 surgeries were conducted per 100,000 population in 2012, which is further expected to supplement the market growth."

Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/404

Pain is a complex medical condition, which not only affects the physical but also mental well-being of an individual. It is caused due to trauma or tissue damage, and its intensity varies from person to person. Based on the cause of pain, the treatment provided can be a simple or complex. Pain can be managed with the help of a variety of pharmacological and non-pharmacological therapies.

The availability of sophisticated treatment options and advancement in technology have increased life the expectancy rates globally, which has resulted in an increase in the geriatric population. As the elderly people are highly prone to suffer from pain owing to various reasons, rise in elderly population is a major factor contributing towards the growth of the global pain management market. As per the statistics provided by the UN Population Division, the total proportion of people above 60 years has increased from 12% in 1950 to 22% in 2011, and is projected to reach 32% by 2050. Moreover, increase in R&D investment and rise in outsourcing of pharmaceuticals are expected to fuel the market growth in developing regions such as Asia-Pacific and LAMEA. However, availability of alternative therapies and patent expiration of prescription drugs for treatment of pain hamper the growth of the market.

The opioids segment is was the largest contributor towards the market growth in 2016, due to high efficiency of opioids to relieve pain in major chronic conditions. Anesthetics is anticipated to possess the highest growth rate during the forecast period.

Postoperative pain and chronic back pain were among the largest contributors in 2016, owing to increase in the number of surgeries globally and rise in prevalence of chronic diseases that lead to back pain. Furthermore, cancer pain is expected to grow at the highest rate throughout the forecast period, owing to rise in prevalence of cancer worldwide.

Get More Information @ https://www.alliedmarketresearch.com/connect-to-analyst/404

North America is expected to generate the highest revenue during forecast period. However, Asia-Pacific is projected to grow at the highest rate during 20172023, due to increase in government initiatives to improve the healthcare infrastructure and improved regulatory framework.

Key Findings of the Pain Management Drugs Market:

• Cancer pain segment is projected to grow at the highest rate during the analysis period.
• Opioids segment generated the highest revenue, and is expected to continue its dominance during the forecast period.
• North America occupied almost half of the market, and is projected to continue its dominance in future.
• China is expected to grow at a CAGR of 6% over the forecast period.
• Postoperative pain was the largest contributor among the indication segment in 2016.

The key companies profiled in the report include

• Novartis AG,
• Eli Lilly & Company,
• Abbott Laboratories,
• Endo Health Solutions, Inc.,
• Purdue Pharma L.P.,
• Pfizer, Inc.,
• F. Hoffmann La Roche Ltd.,
• Merck & Co. Inc.,
• Johnson & Johnson, and
• GlaxoSmithKline Plc.

Other prominent players in the value chain include Allergen Inc., Bayer AG, Bristol-Myers Squibb, Valeant Pharmaceuticals International Inc., Boehringer Ingelheim, Sorrento Therapeutics, WEX Pharmaceuticals, and Zynerba Pharmaceuticals.

Table Of Content

Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTER’S FIVE FORCES ANALYSIS
3.4. REGULATION AND REIMBURSEMENT SCENARIO
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Favorable regulatory scenario
3.5.1.2. Increase in geriatric population
3.5.1.3. Rise in incidence of chronic diseases
3.5.2. Restraints
3.5.2.1. Availability of alternative therapies
3.5.2.2. Drug exploitation
3.5.2.3. Patent expiration of prescription drugs
3.5.3. Opportunities
3.5.3.1. Advancements in drug development
3.5.3.2. Untapped markets in developing economies

Pain Management Drugs Market Summery @ https://www.alliedmarketresearch.com/press-release/pain-management-therapeutics-market.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.